Journal
Psychiatry Research
Publication Date
2-1-2021
Volume
296
First Page
113649
Document Type
Open Access Publication
DOI
10.1016/j.psychres.2020.113649
Rights and Permissions
Rothschild AJ, Parikh SV, Hain D, Law R, Thase ME, Dunlop BW, DeBattista C, Conway CR, Forester BP, Shelton RC, Macaluso M, Brown K, Lewis D, Gutin A, Jablonski MR, Greden JF. Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression. Psychiatry Res. 2021 Feb;296:113649. doi: 10.1016/j.psychres.2020.113649. © 2020 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
Recommended Citation
Rothschild, Anthony J; Conway, Charles R; and et al., "Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression." Psychiatry Research. 296, 113649 (2021).
https://digitalcommons.wustl.edu/oa_4/1414
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
